Attached files
| file | filename |
|---|---|
| EX-23.1 - EXHIBIT 23.1 - Zymergen Inc. | nt10018776x13_ex23-1.htm |
| EX-5.1 - EXHIBIT 5.1 - Zymergen Inc. | nt10018776x13_ex5-1.htm |
As filed with the Securities and Exchange Commission on April 21, 2021.
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Zymergen Inc.
(Exact name of registrant as specified in its charter)
|
Delaware
|
8731
|
46-2942439
|
|
(State or other jurisdiction of
incorporation or organization)
|
(Primary Standard Industrial
Classification Code Number)
|
(I.R.S. Employer
Identification Number)
|
5980 Horton Street, Suite 105
Emeryville CA 94608
(415) 801-8073
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Josh Hoffman
Chief Executive Officer
5980 Horton Street, Suite 105
Emeryville, CA 94608
(415) 801-8073
(Name, address, including zip code, and telephone number, including area code, of agent for service)
With copies to:
|
Sarah K. Solum
Pamela L. Marcogliese
Freshfields Bruckhaus Deringer US LLP
2710 Sand Hill Road
Menlo Park, CA 94025
(650) 618-9250
|
Mina Kim
Zymergen Inc.
5980 Horton Street, Suite 105
Emeryville, CA 94608
(415) 801-8073
|
Rezwan D. Pavri
Andrew T. Hill
Andrew S. Gillman
Wilson Sonsini Goodrich & Rosati, P.C.
650 Page Mill Road
Palo Alto, CA 94304
(650) 493-9300
|
Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes
effective.
If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act
of 1933, check the following box. ☐
If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☒ File No. 333-254612
If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering. ☐
If this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or
an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
|
Non-accelerated filer
|
☒
|
Smaller reporting company
|
☐
|
|
Emerging growth company
|
☒
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new
or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐.
CALCULATION OF REGISTRATION FEE
|
Title of Each Class of
Securities to be Registered
|
|
|
Shares to be
Registered(1)
|
|
|
Proposed
Maximum
Aggregate
Offering Price
Per Share
|
|
|
Proposed
Maximum
Aggregate
Offering
Price
|
|
|
Amount of
Registration
Fee(2)
|
|
Common Stock, par value $0.001 per share
|
|
|
2,909,500 |
|
|
$31.00
|
|
|
$90,194,500
|
|
|
$9,840.22
|
|
(1)
|
Represents only the additional number of shares of common stock being registered and includes 379,500 additional shares of common stock that the underwriters have
the option to purchase. Does not include the securities that the registrant previously registered on the Registration Statement on Form S-1, as amended (File No. 333-254612).
|
|
(2)
|
Calculated pursuant to Rule 457(a) under the Securities Act of 1933, as amended, or the Securities Act, for the purpose of determining the registration fee. The registrant previously
registered securities with a proposed maximum aggregate offering price not to exceed $484,840,000 on the Registration Statement on Form S-1, as amended (File No. 333-254612). In accordance with Rule 462(b) under the Securities Act, an
additional amount of securities having a proposed maximum aggregate offering price of $90,194,500 are hereby registered.
|
This Registration Statement shall become effective upon filing with the Securities and Exchange Commission in accordance with Rule
462(b) of the Securities Act.
EXPLANATORY NOTE AND INCORPORATION OF
CERTAIN INFORMATION BY REFERENCE
Zymergen Inc., a Delaware corporation (the “Registrant”), is filing this Registration Statement with the Securities and Exchange Commission (the “Commission”) pursuant to Rule 462(b) under
the Securities Act of 1933, as amended. This Registration Statement relates to the public offering of securities contemplated by the Registration Statement on Form S-1, as amended (File No. 333-254612) (the “Prior Registration Statement”).
The Registrant is filing this Registration Statement for the sole purpose of increasing by 2,909,500 shares the number of shares of its common stock, par value $0.001 per share, to be
registered for sale, 379,500 of which may be sold by the Registrant upon exercise of the underwriters’ option to purchase additional shares. The additional shares that are being registered for issuance and sale are in an amount and at a price that
together represent no more than 20% of the maximum aggregate offering price set forth in the Calculation of Registration Fee table contained in the Prior Registration Statement. The information set forth in the Prior Registration Statement, and all
exhibits to the Prior Registration Statement, are hereby incorporated by reference into this Registration Statement.
The required opinions and consents are listed on the Exhibit Index attached hereto and filed herewith.
EXHIBIT INDEX
|
Exhibit
Number
|
Description
|
|
|
Opinion of Freshfields Bruckhaus Deringer US LLP.
|
||
|
Consent of Independent Registered Public Accounting Firm.
|
||
|
Consent of Freshfields Bruckhaus Deringer US LLP (included in Exhibit 5.1).
|
||
|
Power of Attorney (included on page II-6 of the Registration Statement on Form S-1 (File No. 333-254612) filed on March 23, 2021).
|
||
|
**
|
Previously filed.
|
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the city of San Francisco, state of California, on the 21st day of April, 2021.
|
Zymergen Inc.
|
||
|
By:
|
/s/ Josh Hoffman
|
|
|
Name:
|
Josh Hoffman
|
|
|
Title:
|
Chief Executive Officer
|
|
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed below by the following persons in the
capacities and on the dates indicated.
|
Name
|
Title
|
Date
|
||
|
/s/ Josh Hoffman
|
Chief Executive Officer (Principal Executive Officer)
|
April 21, 2021
|
||
|
Josh Hoffman
|
||||
|
/s/ Enakshi Singh
|
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
|
April 21, 2021
|
||
|
Enakshi Singh
|
||||
|
*
|
Director
|
April 21, 2021
|
||
|
Steven Chu
|
||||
|
*
|
Director, Chairperson
|
April 21, 2021
|
||
|
Jay T. Flatley
|
||||
|
*
|
Director
|
April 21, 2021
|
||
|
Christine M. Gorjanc
|
||||
|
*
|
Director
|
April 21, 2021
|
||
|
Travis Murdoch
|
||||
|
*
|
Director
|
April 21, 2021
|
||
|
Matthew A. Ocko
|
||||
|
*
|
Director
|
April 21, 2021
|
||
|
Sandra E. Peterson
|
||||
|
*
|
Director
|
April 21, 2021
|
||
|
Zach Serber
|
||||
|
*
|
Director
|
April 21, 2021
|
||
|
Rohit Sharma
|
||||
|
* By:
|
/s/ Enakshi Singh
|
|
|
Enakshi Singh
|
||
|
Attorney-in-Fact
|